Expression and function of the P2X7 purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis

Human Immunology

Volumn 71, Issue 8, 2010, Pages 818-825

  Portales Cervantes, Liliana ^a   Niño Moreno, Perla ^a   Doníz Padilla, Lesly ^a   Baranda Candido, Lourdes ^a,b   García Hernández, Mariana ^a   Salgado Bustamante, Mariana ^a   González Amaro, Roberto ^a   Portales Pérez, Diana ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b Unidad Regional de Reumatología y Osteoporosis Hospital Central   (Mexico)

Author keywords

Apoptosis; Autoimmunity; CD62L; IL 1 ; P2X7 receptor; SNPs

Indexed keywords

ADENOSINE TRIPHOSPHATE; INTERLEUKIN 1BETA; L SELECTIN; PURINERGIC P2X7 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; L-SELECTIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77954761646     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.05.008     Document Type: Article

References (47)

1. Mok C.C., Lau C.S. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003, 56:481-490.
2. Alarcón-Segovia D., Alarcón-Riquelme M.E. Etiopathogenesis of systemic lupus erythematosus: The itineraries of three troikas. Systemic Lupus Erythematosus 2004, Elsevier, New York. R.G. Lahita (Ed.).
3. Prokunina L., Alarcon-Riquelme M. The genetic basis of systemic lupus erythematosus-knowledge of today and thoughts for tomorrow. Hum Mol Genet 2004, 13:R143-R148.
4. Shen N., Tsao B.P. Current advances in the human genetics. Curr Rheumatol Rep 2004, 6:391-398.
5. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
6. Sarraj B., Ludanyi K., Glant T.T., Finnegan A., Mikecz K. Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis. J Immunol 2006, 177:1932-1940.
7. Di Virgilio F. The P2Z purinoreceptor: An intriguing role in immunity, inflammation and cell death. Immunol Today 1999, 16:156-159.
8. Nath S.K., Quintero-Del-Río A.I., Kilpatrick J., Feo L., Ballesteros M., Harley J.B. Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families. Am J Hum Genet 2004, 74:73-82.
9. North R.A. Molecular physiology of P2X receptors. Physiol Rev 2002, 82:1013-1067.
10. Smart M.L., Gu B., Panchal R.G., Willey J., Cromer B., Williams D.A., et al. Receptor cell surface expression and cytolityc pore formation are regulated by a distal C-terminal region. J Biol Chem 2002, 278:8853-8860.
11. 7 receptors. Am J Physiol Cell Physiol 2000, 279:C1189-C1197.
12. 7 receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol Biol Cell 2005, 16:3260-3272.
13. Lister M.F., Sharkey J., Sawatzky D.A., Hodgkiss J.P., Davidson D.J., Rossi A.G., et al. The role of the purinergic P2X7 receptor in inflammation. J Inflamm 2007, 4:5.
14. Baricordi O.R., Melchiorri L., Adinolfi E., Falzoni S., Chiozzi P., Buell G., Di Virgilio F. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem 1999, 274:33206.
15. 7) receptors. Immunity 1997, 7:433-444.
16. Ferrari D., Wesselborg S., Bauer M.K., Schulze-Osthoff K. Extracellular ATP activates transcription factor NF-kappaB trough the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J Cell Biol 1997, 139:1635-1643.
17. 7 nucleotide receptor. J Biol Chem 2000, 275:26792-26798.
18. 7 receptors. J Biol Chem 2005, 280:33968-33976.
19. 7 receptor: A key player in IL-1beta processing and release. J Immunol 2006, 176:3877-3883.
20. Gu B., Bendall L.J., Wiley J.S. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 1998, 92:946-951.
21. 7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 2002, 168:6436-6445.
22. 7 purinoreceptor gene abolishes chronic inflammatory and neurophatic pain. Pain 2005, 114:386-396.
23. Gu B.J., Sluyter R., Skarratt K.K., Shemon A.N., Dao-Ung L.P., Fuller S.J., et al. An Arg-307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 2004, 23:31287-31295.
24. 7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 2005, 27:2079-2086.
25. 7 receptor. J Cell Biol 2001, 276:11135-11142.
26. 7R impairs ATP-induced IL-1β release from human monocytes. J Immunol 2004, 3399-3405.
27. 7 receptor. J Biol Chem 2003, 278:17108-17113.
28. 7 gene with tuberculosis in a Gambian population. J Infect Dis 2002, 186:1458-1462.
29. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
30. Guzmán J., Cardiel M.H., Arce-Salinas A., Sánchez-Guerrero J., Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus: Prospective validation of 3 clinical indices. J Rheumatol 1992, 19:1551-1558.
31. 7 receptor is a candidate product of murine and human lupus susceptibility loci: A hypothesis and comparison of murine allelic products. Arthritis Res Ther 2005, 7:R468-R475.
32. Guo C., Masin M., Qureshi O.S., Murrell-Lagnado R.D. Evidence for functional P2X4/P2X7 heteromeric receptors. Mol Pharmacol 2007, 72:1447-1456.
33. Klapperstück M.Büttner C., Böhm T., Schmalzing G., Markwardt F. Characteristics of P2X7 receptors from human B lymphocytes expressed in Xenopus oocytes. Biochim Biophys Acta 2000, 25:444-456.
34. Cheewatrakoolpong B., Gilchrest H., Anthes J.C., Greenfeder S. Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem Biophys Res Commun 2005, 332:17-27.
35. Li C.M., Campbell S.J., Kumararatne D.S., Hill A.V., Lammas D.A. Response heterogeneity of human macrophages to ATP is associated with P2X7 receptor expression but not to polymorphisms in the P2RX7 promoter. FEBS Lett 2002, 531:127-131.
36. Zhou L., Qi X., Potashkin J.A., Abdul-Karim F.W., Gorodeski G.I. MicroRNAs miR-186 and miR-150 down-regulate expresión of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 2006, 283:28274-28286.
37. Forchap S.L., Anandacoomarasamy A., Wicks J., Di Virgilio F., Baricordi O.R., Rubbini M., et al. P2X7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus. Tissue Antigens 2008, 72:487-490.
38. Alvarado-Sánchez B., Hernández-Castro B., Portales-Pérez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006, 27:110-118.
39. + regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: A role for P2X7 receptors. J Immunol 2005, 175:3075-3083.
40. Kim M., Jiang L.H., North R.A., Surprenant A. Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J 2001, 15:6347-6358.
41. + stem and progenitor cells. BMC Immunol 2004, 3:5-16.
42. Stokes L., Surprenant A. Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation. Eur J Immunol 2009, 39:986-995.
43. Taylor S.R., Gonzalez-Begne M., Sojka D.K., Richardson J.C., Sheardown S.A., Harrison S.M., et al. Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. J Leukoc Biol 2009, 85:978-986.
44. + T cells in peripheral blood of rheumatoid arthritis patients. Arthritis Res Ther 2003, 5:R91-R96.
45. Bond A., Hay F.C. L-selectin expression on the surface of peripheral blood leucocytes from rheumatoid arthritis patients is linked to disease activity. Scand J Immunol 1997, 46:312-316.
46. Schneider E.M., Vorlaender K., Ma X., Du W., Weiss M. Role of ATP in trauma-associated cytokine release and apoptosis by P2X7 ion channel stimulation. Ann NY Acad Sci 2006, 1090:245-252.
47. Perregaux D.G., McNiff P., Laliberte R., Conklyn M., Gabel C.A. ATP acts as an agonist to promote stimulus-induced secretion of IL-1β and IL-18 in human blood. J Immunol 2000, 165:4615-4623.